University of Crete
Heraklion, Crete, 71110, Greece
Location status: Recruiting
NCT Number: NCT04894864
Open Abdominal Aortic Aneurysm (AAA) repair is a high-risk surgical procedure accompanied by intense endocrine and metabolic responses to surgical stress, with subsequent activation of the inflammatory cascade, cytokine and acute-phase protein release, and bone marrow activation. There is a proven correlation of surgical stress, which patients undergoing open AAA repair are subjected to, with patient outcome, morbidity/mortality, intensive care unit stay and overall length of stay. Modern general anesthetic techniques have been revised and rely on perioperative multimodal anesthetic and analgesic strategies for improved overall patient outcome. Based on this context of a multimodal anesthetic technique and having taken into consideration the international "opioid-crisis" epidemic, an Opioid Free Anesthesia-Analgesia (OFA-A) strategy started to emerge. It is based on the administration of a variety of anesthetic/analgesic agents with different mechanisms of action, including immunomodulating and anti-inflammatory effects.
Our basic hypothesis is that the implementation of a perioperative multimodal OFA-A strategy, involving the administration of pregabalin, ketamine, dexmedetomidine, lidocaine, dexamethasone, dexketoprofen, paracetamol and magnesium sulphate, will lead to attenuation of surgical stress response compared to a conventional Opioid-Based Anesthesia-Analgesia (OBA-A) strategy. Furthermore, the anticipated attenuation of the inflammatory response, is pressumed to be associated with equal or improved analgesia, compared to a perioperative OBA-A technique.
Interested in participating?
Request Info40 year–85 year
All sexes
Interventional
Phase 4
Heraklion, Crete, 71110, Greece
Location status: Recruiting
Open abdominal aortic aneurysm (AAA) repair surgery is a high-risk operation, often performed on high-risk patients. Despite advancements made in diagnosis, management, surgical techniques and treatment of these patients, morbidity and mortality remain high. Mortality after open AAA repair remains higher than the average mortality of the matched population for age and sex. Debate is ongoing as to whether open AAA repair or endovascular aneurysm repair (EVAR) is better in terms of overall long-term survival rate.
Regarding open AAA repair, the very nature of the surgery itself, with surgical trauma, aortic cross clamping and its resulting ischemia-reperfusion injury, and cellular interactions of blood with the biomaterial surface of the graft, causes intense and varied metabolic, endocrine and immunological responses. These surgical stress-related responses are evident as marked increases in inflammatory cytokines such as TNF-a, IL-1a, IL-6, IL-8, IL-10, stimulation of the sympathetic system, and stimulation of the hypothalamic-pituitary-adrenal axis, caused by release of CRH and AVP. High levels of IL-6, peaking at 4-48h after clamp removal, have been associated with serious postoperative complications and its levels reflect the intensity of surgical trauma following AAA repair. Other inflammation markers such as CRP and leukocytes have also been shown to increase postoperatively.
While the surgical technique has been extensively studied as to the role it plays on the control of the surgical stress response, patient outcome, morbidity and overall mortality, fewer studies have been conducted to study the effect of the anesthetic management on these factors. While most of them have been focusing on the comparison of general anesthetic vs regional techniques, only few compare different general anesthetic techniques on patient outcome.
Modern general anesthetic techniques have been revised and rely on a multimodal anesthetic and analgesic perioperative regimen for improved patient outcome. A multimodal regimen requires the administration of at least 2 factors with different mechanisms of action. At least one factor causes inhibition of central sensitization and at least another one inhibits the peripheral sensitization of the nervous system, as a response to painful surgical stimuli, mitigating adverse neuroplasticity. One such example, is an Opioid-Free Anesthetic-Analgesic (OFA-A) strategy, which implements a variety of pharmacological agents, including some with demonstrated immunomodulating and anti-inflammatory effects. Apart from sparing any opioid-related adverse effects, an OFA-A multimodal strategy targets optimal analgesia with a multitude of factors in the lowest possible dose, aiming for additive or synergistic effects. An additional advantage of using an OFA-A technique is the prevention of opioid-induced hyperalgesia.
Our hypothesis is that implementation of a multimodal OFA-A strategy, leads to a decreased sympathetic and inflammatory response, compared to conventional opioid-based anesthetic techniques. A decreased inflammatory and stress response as expressed by reduced levels of IL-6, IL-8, IL-10, TNF-a, CRP, cortisol, arginine vasopressin (AVP), white blood cells count and hemodynamic stability is expected to decrease peripheral and central sensitization, contributing to better postoperative analgesia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A perioperative Opioid-Based multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Based arm of the study.
Other names: Opioid-Based Anesthesia, OBA-A
A perioperative Opioid-Free multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Free arm of the study.
Other names: Opioid-Free Anesthesia, OFA-A
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.
Time frame: 1) Preoperatively (as a baseline)
Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.
Time frame: 2) 15 minutes after aortic cross-clamping
Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.
Time frame: 3) 60 minutes after aortic cross-clamp release
Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.
Time frame: 4) 24 hours after aortic cross-clamp release
Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Intraoperative Tachycardia (defined as PR≥ 100 bpm), with episodes lasting ≥1 minute. Data will be reported in as a percentage of the total surgical time in which the participant exhibited tachycardia.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Intraoperative Bradycardia (defined as PR≤ 40 bpm), with episodes lasting ≥1 minute. Data will be reported in as a percentage of the total surgical time in which the participant exhibited bradycardia.
Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Intraoperative Hypotension (defined as SBP≤90mmHg or ≤80% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypotension, based on the SBP values.
Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Intraoperative Hypotension (defined as MBP≤65mmHg or ≤80% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative MBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute MPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypotension, based on the MBP values.
Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Intraoperative Hypertension (defined as SBP ≥120% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypertension, based on the SBP values.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements averaged over the total surgical time. Data will be reported in ml/kg*h.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements. Data will be reported in ml/kg*h.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements averaged over the total surgical time. Data will be reported in ml/kg*h.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements. Data will be reported in ml/kg*h.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance averaged over the total surgical time. Data will be reported in ml/kg/h
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance. Data will be reported in ml.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged rate in mcg/kg*min.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements.Data will be reported as an averaged rate in mcg/kg*min.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged rate in mcg/kg*min.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged rate in mcg/kg*min.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg*min.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged rate in mcg/kg*min.
Time frame: 1) Immediately postoperatively (if awakened prior to ICU admission)
Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").
Time frame: 2) First postoperative day
Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").
Time frame: 3) Second postoperative day
Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").
Time frame: 4) Third postoperative day
Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").
Time frame: 1) Immediately postoperatively (if awakened prior to ICU admission)
Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).
Time frame: 2) First postoperative day
Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).
Time frame: 3) Second postoperative day
Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).
Time frame: 4) Third postoperative day
Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Intolerable" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Intolerable" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Intolerable" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Tolerable with discomfort" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Tolerable with discomfort" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Tolerable with discomfort" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Comfortably manageable" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Comfortably manageable" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Comfortably manageable" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Negligible Pain" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Negligible Pain" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be:
The percentage of patients that report pain that is "Negligible Pain" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting worse" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting worse" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting worse" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "About the same" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "About the same" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "About the same" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting better" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting better" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be:
The percentage of patients that report pain that is "Getting better" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report "Inadequate pain control" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report "Inadequate pain control" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report "Inadequate pain control" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report pain control that is "Effective, just about right" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report pain control that is "Effective, just about right" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients that report pain control that is "Effective, just about right" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be:
The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be:
The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Normal sleep" will be reported
Time frame: 2) Second postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Normal sleep" will be reported
Time frame: 3) Third postoperative day
Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be:
The percentage of patients whose sleep is reported as "Normal sleep" will be reported
Time frame: 1) First postoperative day
Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.
Time frame: 2) Second postoperative day
Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.
Time frame: 3) Third postoperative day
Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.
Time frame: 1) Preoperatively (as a baseline)
Kidney function as assessed by preoperative GFR calculated by the MDRD GFR equation.
Time frame: 2) At the end of surgery 1h after the end of placement of last suture/surgical clip on patient, upon ICU admission.
Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.
Time frame: 3) 24h postoperatively
Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.
Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours
Kidney function as quantified by urine output. Data will be reported as an averaged intraoperative rate in ml/kg*h.
Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively
Kidney function as quantified by urine output. Data will be reported as an averaged rate in ml/kg*h.
Time frame: From day of surgery until day of ICU stay.
All patients will spend at least 1 day in the ICU for postoperative monitoring. ICU length of stay will be reported in days.
Time frame: From day of surgery until hospital discharge
Hospital length of stay will be reported in days.
Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of the PR values will be reported for each patient, extracted from the collected data.
Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.
Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of SBP values will be reported for each patient, extracted from the collected data.
Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.
Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of DBP values will be reported for each patient, extracted from the collected data.
Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.
Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of MBP values will be reported for each patient, extracted from the collected data.
Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.
Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Pressure. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of PP values will be reported for each patient, extracted from the collected data.
Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the PP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.
Contact information is provided by the study sponsor or research team.
George Papastratigakis, MD
CONTACT
Georgios Stefanakis, MD
CONTACT
University of Crete
Other
Effect of a Perioperative Opioid Free Anesthesia-Analgesia (OFA-A) Strategy on Surgical Stress Response in Elective Open Abdominal Aortic Aneurysm Repair: A Prospective Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03420586
Anesthesia Recovery Period, Anesthesia, General
Zadar, Croatia
View Trial DetailsNCT05841667
Adult, Elective Surgical Procedures
Seoul, South Korea
View Trial DetailsNCT07590141
Elective Surgical Procedures, Pathologic Processes
Hamilton, Ontario, Canada
View Trial DetailsNCT04721405
Elective Surgical Procedures
New York, United States
View Trial Details